Dr Pamela Parker is a leading figure in ultrasound imaging and prostate cancer care. Beginning as a diagnostic radiographer, she advanced ultrasound practices to improve patient care, from liver cancer detection to innovative prostate biopsy techniques. Dr Pamela Parker’s commitment to advancing sonography has set new standards in the field.
This article highlights Dr Pamela Parker journey and her impact on the future of medical imaging.
Introduction to a Remarkable Career in Ultrasound
In 1995, Pamela Parker embarked on her journey into ultrasound after qualifying as a diagnostic radiographer two years earlier. Her fascination with ultrasound stemmed from its unique blend of investigative depth, patient interaction, and technological advancement. This passion laid the foundation for an extraordinary career dedicated to pioneering advancements in medical imaging, particularly in prostate cancer research, culminating in her recent PhD. Through dedication and innovation, she has made substantial contributions to patient care and imaging technologies.
Pamela’s career in ultrasound began at a time when the field was still emerging. Driven by a passion for learning, she specialised in hepatobiliary, urology, and paediatric imaging. By 2004, Pamela and her team introduced a contrast-enhanced ultrasound (CEUS) service, enabling more precise imaging for liver metastasis in colorectal cancer patients. This innovation marked her entry into the forefront of ultrasound technology, where she continually embraced advancements to improve patient outcomes.
Impactful Research in Prostate Cancer Care
Among Pamela’s most significant projects has been her work on prostate cancer diagnosis and surveillance. Addressing a critical gap in accessibility, her research focused on using micro-ultrasound (microUS) to support active surveillance in prostate cancer cases, providing an alternative to MRI scans. Although her research identified limitations in microUS for clinical use, it highlighted both the potential and the challenges of integrating new imaging technologies in prostate cancer care.
Separately, a central factor in Pamela’s research was the Canon Medical ultrasound technology. In 2014, a donation from a patient’s family allowed her department to acquire a Canon fusion-guided ultrasound system, which fuses real-time ultrasound with MRI or CT images to enhance biopsy accuracy. According to Pamela’s citation[1], this technology transformed prostate biopsies by enabling targeted, transperineal biopsy techniques that boosted cancer detection rates to 97% while minimising post-procedural risks.
Transforming the Sonography Profession
Pamela’s leadership went beyond clinical practice, leaving a lasting impact on the sonography profession. In her management roles, she advocated for clear career pathways and professional standards, establishing roles such as the Consultant Sonographer position. Her influence led to the creation of advanced practice roles aligned with the four pillars of practice: clinical expertise, education, research, and leadership. This structure has not only provided career progression but has also attracted and retained talent within the field.
This commitment to advancing ultrasound extended to her work with the British Medical Ultrasound Society (BMUS), where she began supporting its professional activities in 2002 and became proactively involved from 2013, later serving as President from 2020 to 2022. During her tenure, she championed initiatives to develop profession-specific guidance and standards that continue to shape clinical practices today. As chair of the HEE (Health Education England) Sonographer Workforce Group, she helped establish the national Career and Progression Framework for Sonographers, a significant step in formalising the profession’s standards and supporting new roles within the healthcare system.
A Legacy of Patient-Centred Innovation
A testament to patient-centred innovation in ultrasound and imaging technology, Pamela’s career highlights the power of Canon Medical’s ultrasound technology in bridging academic research with practical application. This has enhanced diagnostic accuracy and patient safety in prostate cancer care. Canon Medical’s technological support empowered Pamela to push ultrasound’s potential, leading to transformative changes in healthcare practices.
In July 2024, Dr Pamela Parker achieved a PhD, marking the pinnacle of a 30-year journey from sonographer to consultant and now researcher. Her career demonstrates the profound impact of combining clinical experience with research, highlighting the value of partnerships between healthcare professionals and technology providers. Pamela’s legacy continues to inspire, setting a benchmark for future generations in advancing healthcare through dedication, innovation, and collaboration.
To learn more from Dr Pamela Parker, visit the Canon Medical Academy website, where you can gain valuable insights into prostate cancer care and earn 1 CPD point. Drawing on her extensive expertise in prostate ultrasound, Pamela explores the current state of histology and survival rates, treatment decision-making, diagnostic challenges, and future opportunities in prostate ultrasound imaging.
[1] A proof of concept study evaluating the role of emerging ultrasound technologies in the active surveillance of localised prostate cancer